FDA authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 vaccines for use as a booster dose in younger age groups
WASHINGTON, D.C. – On Wednesday, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups. The Moderna COVID-19 Vaccine, Bivalent is authorized for administration at least two months […]